Heterozygous Germline Fanconi Anemia–Related Gene Mutations Increase Susceptibility to Germ Cell Tumors
JCO Precision Oncology · 2025
DOI: 10.1200/po-25-00435 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2025. Verfasst von Jing Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Jining No.1 People's Hospital, Jining, China. Hauptthemen laut MEDLINE: Germ-Line Mutation, Neoplasms, Germ Cell and Embryonal, Genetic Predisposition to Disease, Fanconi Anemia. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE Germ cell tumors (GCTs) are a heterogeneous group of neoplasms that predominantly affect adolescents and young adults. Notably, geographical disparities in GCT incidence exist, with higher rates observed in East Asia. Although numerous studies have established links between heterozygous germline mutations in Fanconi anemia (FA) genes and the development of certain human cancers, the association between germline pathogenic or likely pathogenic (P/LP) variants in FA genes and the relative risk of developing GCTs remains incompletely characterized. METHODS In this study, we used next-generation sequencing (NGS) to investigate the genetic susceptibility patterns of Chinese patients with GCTs for the first time. We investigated the association between germline P/LP variants in FA-related genes and the risk of developing GCTs. Furthermore, we compared clinical characteristics, mutational landscape, and mutational signatures between patients with and without germline P/LP variants in FA-related genes. RESULTS We identified heterozygous germline P/LP variants in FA-related genes in 12.12% (8/66) of patients with GCTs, involving FANCA , BRCA2 , FANCD2 , FANCE , and SLX4 . Our findings demonstrate a significant association between a subset of FA genes and an increased relative risk of GCTs, indicating a role for these variants in GCT predisposition. Furthermore, patients harboring these FA gene variants exhibited a higher number of mutations, increased propensity for gene fusions, and demonstrated a greater degree of genomic instability. CONCLUSION These results elucidate the contribution of FA-related germline variants to GCT pathogenesis and advance our understanding of the genetic determinants influencing GCT relative risk. This research provides a basis for developing more effective screening strategies, personalized treatment approaches, and improved patient management strategies for GCTs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Jining No.1 People's Hospital, Jining, China.
- The Medical Department, Jiangsu Simcere Diagnostics Co, Ltd, Nanjing Simcere Medical Laboratory Science Co, Ltd, The State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, China.
- Department of Biological Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, China.
- Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
- Department of Neurosurgery, Children's Hospital Affiliated to Shandong University, Jinan, China.
ORCID-Profile: Guangyu Wang
Zitieren
APA
Wang, J., Luo, N., Han, T., Yin, X., & Wang, G. (2025). Heterozygous Germline Fanconi Anemia–Related Gene Mutations Increase Susceptibility to Germ Cell Tumors. JCO Precision Oncology. https://doi.org/10.1200/po-25-00435
Vancouver
Wang J, Luo N, Han T, Yin X, Wang G. Heterozygous Germline Fanconi Anemia–Related Gene Mutations Increase Susceptibility to Germ Cell Tumors. JCO Precision Oncology. 2025. doi:10.1200/po-25-00435
BibTeX
@article{Wang2025,
author = {Wang, Jing and Luo, Ningning and Han, Tiantian and Yin, Xiangyu and Wang, Guangyu},
title = {Heterozygous Germline Fanconi Anemia–Related Gene Mutations Increase Susceptibility to Germ Cell Tumors},
journal = {JCO Precision Oncology},
year = {2025},
doi = {10.1200/po-25-00435}
}
EUVIMED